Equities

electroCore, Inc.

electroCore, Inc.

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.46
  • Today's Change0.459 / 7.65%
  • Shares traded41.33k
  • 1 Year change+18.75%
  • Beta0.6169
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.

  • Revenue in USD (TTM)21.28m
  • Net income in USD-14.23m
  • Incorporated2005
  • Employees68.00
  • Location
    electroCore, Inc.200 FORGE WAY, SUITE 205ROCKAWAY 07866United StatesUSA
  • Phone+1 (973) 290-0097
  • Fax+1 (973) 290-9171
  • Websitehttps://www.electrocore.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
United Health Products Inc0.00-1.84m31.65m6.00---------0.0075-0.00750.00-0.00810.000.00--0.00-662.95-6,446.86------53.19---132,561.200.0126-15.12-----100.00---55.45------
Icecure Medical Ltd3.34m-13.69m31.69m71.00--2.99--9.50-0.2934-0.29340.07140.21430.17530.843615.0646,985.91-71.93-54.89-92.10-68.6640.3249.87-410.22-313.192.54--0.00--4.6723.5013.70--48.10--
Vaso Corp80.33m2.26m32.97m300.0012.181.2310.520.41050.01540.01540.45710.15241.1022.599.62267,766.703.107.605.0416.6261.2058.392.815.821.48--0.0028--2.181.84-57.46---22.33--
Vicarious Surgical Inc0.00-61.02m33.97m131.00--0.4714-----10.77-10.770.0012.220.00----0.00-61.68---66.62--------------0.00-------1,478.15------
BioNano Genomics Inc36.58m-204.10m34.87m344.00--0.3572--0.9533-5.15-5.150.74961.140.18261.005.28106,334.30-101.86-56.82-123.67-67.8328.9725.38-557.98-505.761.11-61.510.0455--29.9024.65-75.34--38.51--
Accelerate Diagnostics Inc12.23m-37.91m36.47m134.00------2.98-2.07-2.070.6853-1.470.33632.145.2891,291.05-104.22-75.24-1,349.93-94.4627.1635.08-309.87-638.551.04--6.38---5.4316.291.40--0.7307--
Rapid Micro Biosystems Inc24.71m-50.46m37.72m193.00--0.3987--1.53-1.17-1.170.57112.200.17781.335.58128,036.30-36.30---40.86---14.22---204.22--4.62--0.003--31.44--13.71------
T2 Biosystems Inc7.16m-48.26m38.28m113.00------5.34-10.70-10.701.09-0.33910.24352.825.4163,398.23-164.01-106.01---253.03-86.96-12.60-673.67-317.930.359-12.442.00---67.75-7.2919.66---20.19--
Movano Inc852.00k-26.83m38.96m30.00--2.32--45.72-0.4527-0.45270.01310.16960.0444--3.3828,400.00-139.74-151.50-176.37-188.58-87.21---3,149.06--5.23--0.0025------3.45--4.24--
Precision Optics Corporation Inc19.41m-1.64m39.37m84.00--3.34--2.03-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
Co-Diagnostics Inc9.14m-37.57m41.17m155.00--0.5686--4.51-1.27-1.270.30772.270.09441.1911.0858,948.20-38.835.77-41.046.1559.8382.24-411.1910.948.81--0.000.00-80.09179.54-148.15--101.27--
electroCore, Inc.21.28m-14.23m41.65m68.00--3.63--1.96-2.19-2.193.251.781.161.4154.85312,955.90-77.78-70.73-125.05-88.9683.6175.81-66.84-352.822.12--0.00--86.5774.4215.02---5.88--
iCAD Inc18.80m-4.54m41.93m67.00--1.34--2.23-0.1735-0.0880.71851.170.44881.063.14280,537.30-10.84-23.94-13.90-34.1486.0476.96-24.16-45.024.13--0.00---12.54-7.5329.32--23.88--
Lucid Diagnostics Inc3.80m-54.15m44.54m70.00------11.72-1.23-1.230.08570.32380.0992--38.9754,285.71-121.82---274.96---67.39---1,227.76--1.71--0.4178--544.03--6.24------
Apyx Medical Corp49.03m-28.37m45.04m252.00--3.05--0.9185-0.8188-0.81881.420.42570.76721.823.96194,567.50-44.55-25.24-58.21-29.9761.9066.11-58.08-46.004.45-7.790.693--17.6125.8219.28--7.99--
Adagio Medical Holdings Inc0.00-2.54m51.54m----1.29-----0.1856-0.18560.002.990.00-------6.73---9.12--------------0.1226-------299.85------
Data as of Sep 20 2024. Currency figures normalised to electroCore, Inc.'s reporting currency: US Dollar USD

Institutional shareholders

20.54%Per cent of shares held by top holders
HolderShares% Held
AWM Investment Co., Inc.as of 31 Mar 2024550.36k8.83%
MAZ Capital Advisors LLCas of 15 Jun 2024271.96k4.37%
The Vanguard Group, Inc.as of 31 Mar 2024159.93k2.57%
Renaissance Technologies LLCas of 30 Jun 202468.79k1.10%
International Assets Investment Management LLCas of 30 Jun 202467.82k1.09%
Geode Capital Management LLCas of 30 Jun 202457.53k0.92%
Wealthspire Advisors LLCas of 30 Jun 202447.50k0.76%
Jaffe Tilchin Investment Partners LLCas of 30 Jun 202426.28k0.42%
PFG Investments LLCas of 30 Jun 202418.00k0.29%
SSgA Funds Management, Inc.as of 31 Mar 202411.67k0.19%
More ▼
Data from 31 Mar 2024 - 16 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.